高级检索
贾祥鹤, 付振涛, 姜帆, 鹿子龙, 郭晓雷, 贾存显. 山东省居民2013 — 2018年肝癌发病和死亡趋势分析[J]. 中国公共卫生, 2023, 39(10): 1315-1320. DOI: 10.11847/zgggws1141289
引用本文: 贾祥鹤, 付振涛, 姜帆, 鹿子龙, 郭晓雷, 贾存显. 山东省居民2013 — 2018年肝癌发病和死亡趋势分析[J]. 中国公共卫生, 2023, 39(10): 1315-1320. DOI: 10.11847/zgggws1141289
JIA Xianghe, FU Zhentao, JIANG Fan, LU Zilong, GUO Xiaolei, JIA Cunxian. Trends in liver cancer incidence and mortality in Shandong province, 2013 – 2018: cancer registry data analysis[J]. Chinese Journal of Public Health, 2023, 39(10): 1315-1320. DOI: 10.11847/zgggws1141289
Citation: JIA Xianghe, FU Zhentao, JIANG Fan, LU Zilong, GUO Xiaolei, JIA Cunxian. Trends in liver cancer incidence and mortality in Shandong province, 2013 – 2018: cancer registry data analysis[J]. Chinese Journal of Public Health, 2023, 39(10): 1315-1320. DOI: 10.11847/zgggws1141289

山东省居民2013 — 2018年肝癌发病和死亡趋势分析

Trends in liver cancer incidence and mortality in Shandong province, 2013 – 2018: cancer registry data analysis

  • 摘要:
      目的  分析山东省居民2013 — 2018年肝癌的发病和死亡趋势,为肝癌的预防控制提供参考依据。
      方法  收集2021年山东省35个肿瘤登记处提交的2018年肿瘤登记数据,经过严格质量控制后对2013 — 2018年肝癌发病和死亡数据不同年份的发病率和死亡率及其标化率进行计算,并采用Joinpoint 4.8.0.1软件计算肝癌发病率和死亡率的年度变化百分比(APC)。
      结果  山东省居民2013 — 2018年肝癌发病率和标化发病率依次为29.86/10万和19.51/10 万、30.26/10 万和18.94/10 万 、27.99/10 万和 17.33/10 万、29.57/10 万和17.39/10 万、26.80/10 万 和15.73/10 万、26.31/10 万和15.18/10 万,居民肝癌发病率和标化发病率均呈总体下降趋势(APC = – 2.7%和 – 5.0%,均P < 0.05);山东省居民2013 — 2018年肝癌死亡率和标化死亡率依次为26.13/10万和16.87/10 万、26.07/10 万和16.13/10 万 、24.08/10 万和 14.70/10 万、23.12/10 万和13.08/10 万、23.69/10 万 和13.69/10 万、23.12/10 万和13.08/10 万,居民肝癌死亡率和标化死亡率均呈总体下降趋势(APC = – 2.6%和 – 5.1%,均P < 0.01);山东省居民2013 — 2018年肝癌发病占全部恶性肿瘤发病比例依次为36.65%、36.36%、32.81%、31.68%、28.66%、28.13%,肝癌死亡占全部恶性肿瘤死亡比例依次为29.58%、28.95%、26.76%、24.59%、23.47%、22.54%;不同特征居民中,男性、女性、35岁~、40岁~、45岁~、50岁~、55岁~、60岁~、65岁~、75岁~和80岁~居民2013 — 2018年的肝癌发病率均呈下降趋势(均P < 0.05),男性、女性、城市和农村居民2013 — 2018年的肝癌标化发病率均呈下降趋势(均P < 0.05),男性、城市、40岁~ 、45岁~ 、55岁~ 、60岁~ 、75岁~ 和80岁~ 居民2013 — 2018年的肝癌死亡率均呈下降趋势(均P < 0.05),男性、女性、城市和农村居民2013 — 2018年的肝癌标化死亡率均呈下降趋势(均P < 0.05)。
      结论  山东省居民2013 — 2018年肝癌总体发病率和死亡率均呈下降趋势,但发病和死亡比例依然较高。

     

    Abstract:
      Objective  To analyze the trend in liver cancer incidence and mortality in Shandong province during 2013 – 2018 for providing evidence to the prevention and control of liver cancer.
      Methods  The data of 2013 – 2018 on liver cancer incidence and mortality among residents covered by 35 tumor registries across Shandong province were extracted from tumor registry system of the province. After data cleaning, annual crude and standardized (based on national population of China 2000 census) incidence and mortality rate of liver cancer among the residents were calculated. Joinpoint 4.8.0.1 software was used to estimate the annual percentage change (APC) in liver cancer incidence and mortality rate.
      Results  From 2013 to 2018 among the residents, the annual crude incidence rate (1/100 000) of liver cancer were 29.86, 30.26, 27.99, 29.57, 26.80, and 26.31 and the annual standardized incidence rate (1/100 000) were 19.51, 18.94, 17.33, 17.39, 15.73, and 15.18, respectively; both the crude and standardized incidence rate of liver cancer showed an overall decreasing trend, with the APC of – 2.7% and – 5.0% (both P < 0.05) ; the annual crude mortality rate (1/100 000) and standardized mortality rate (1/100 000) of liver cancer also presented an overall decreasing trend during the 6-year period, with the annual crude rate of 26.13, 26.07, 24.08, 23.12, 23.69, and 23.12 for incidence and 16.87, 16.13, 14.70, 13.08, 13.69 and 13.08 for mortality rate (APC = – 2.6% and – 5.1%, both P < 0.01); the annual incidents of liver cancer accounted for 36.65%, 36.36%, 32.81%, 31.68%, 28.66%, and 28.13% of all newly diagnosed malignant tumors per year and the annual number of deaths due to liver cancer accounted for 29.58%, 28.95%, 26.76%, 24.59%, 23.47%, and 22.54% of all malignant tumor deaths yearly for years 2013 – 2018. Also for the years 2013 – 2018, the age-specific (five year age group) liver cancer incidence rate decreased significantly among the male and female residents aged elder than 34 years and younger than 85 years (P < 0.05 for all); the age-specific liver cancer mortality rate decreased during the same period among the male and urban residents aged elder than 39 years and younger than 85 years (P < 0.05 for all); the decreasing trends in annual standardized incidence and mortality rate of liver cancer were significant for subgroups of male, female, urban, and rural populations (P < 0.05 for all).
      Conclusion  During 2013 to 2018, the overall incidence and mortality rate of liver cancer showed a decreasing trend among the residents in Shandong province, but the incidence and mortality rate were still at a high level.

     

/

返回文章
返回